Department of Obstetrics and Gynaecology, University of Brescia, Spedali Civili di Brescia, Brescia, Italy.
Department of Obstetrics and Gynecology, Academic Medical Centre, Amsterdam, Netherlands.
Ultraschall Med. 2021 Feb;42(1):56-64. doi: 10.1055/a-0972-1098. Epub 2019 Sep 2.
To investigate the effects of the antenatal administration of betamethasone on fetal Doppler and short term fetal heart rate variation (CTG-STV) in early growth restricted (FGR) fetuses.
Post hoc analysis of data derived from the TRUFFLE study, a prospective, multicenter, randomized management trial of severe early onset FGR. Repeat Doppler and CTG-STV measurements between the last recording within 48 hours before the first dose of betamethasone (baseline value) and for 10 days after were evaluated. Multilevel analysis was performed to analyze the longitudinal course of the umbilico-cerebral ratio (UC ratio), the ductus venosus pulsatility index (DVPIV) and CTG-STV.
We included 115 fetuses. A significant increase from baseline in CTG-STV was found on day + 1 (p = 0.019) but no difference thereafter. The DVPIV was not significantly different from baseline in any of the 10 days following the first dose of betamethasone (p = 0.167). Multilevel analysis revealed that, over 10 days, the time elapsed from antenatal administration of betamethasone was significantly associated with a decrease in CTG-STV (p = 0.045) and an increase in the DVPIV (p = 0.001) and UC ratio (p < 0.001).
Although steroid administration in early FGR has a minimal effect on increasing CTG-STV one day afterwards, the effects on Doppler parameters were extremely slight with regression coefficients of small magnitude suggesting no clinical significance, and were most likely related to the deterioration with time in FGR. Hence, arterial and venous Doppler assessment of fetal health remains informative following antenatal steroid administration to accelerate fetal lung maturation.
研究产前给予倍他米松对胎儿多普勒和短期胎儿心率变异(CTG-STV)的影响在早期生长受限(FGR)胎儿中。
对 TRUFFLE 研究的数据进行了事后分析,这是一项针对严重早发性 FGR 的前瞻性、多中心、随机管理试验。评估了在第一次倍他米松给药前 48 小时内的最后一次记录(基线值)前后 10 天的重复多普勒和 CTG-STV 测量值。进行了多层次分析,以分析脐-脑比值(UC 比值)、静脉导管搏动指数(DVPIV)和 CTG-STV 的纵向变化。
我们纳入了 115 例胎儿。在第 1 天(p=0.019)发现 CTG-STV 从基线显著增加,但此后无差异。在第一次倍他米松给药后的 10 天内,DVPIV 与基线无显著差异(p=0.167)。多层次分析显示,在 10 天内,从产前给予倍他米松到时间的流逝与 CTG-STV 的降低(p=0.045)、DVPIV 的增加(p=0.001)和 UC 比值的增加(p<0.001)显著相关。
尽管在早期 FGR 中给予类固醇后 CTG-STV 在一天后增加的效果很小,但对多普勒参数的影响极小,回归系数幅度较小,表明没有临床意义,并且很可能与 FGR 随时间的恶化有关。因此,在加速胎儿肺成熟的情况下,产前类固醇给药后对胎儿健康的动脉和静脉多普勒评估仍然具有信息性。